Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Dana-Farber Cancer Institute patents focal adhesion kinase inhibitors

Dec. 10, 2020

New aryl hydrocarbon receptor antagonists disclosed by Antidote IP Holdings

Dec. 10, 2020

FDA clears IND for first-in-human study of KB-0742 for MYC-amplified tumors

Dec. 9, 2020

Teligene identifies new protein kinase inhibitors

Dec. 9, 2020

ACSS2 inhibitors discovered at Metabomed

Dec. 9, 2020

ION-251 enters first-in-human trial for relapsed or refractory multiple myeloma

Dec. 9, 2020

Enrollment open in phase Ib/II study of KRT-232 with acalabrutinib in DLBCL and CLL

Dec. 9, 2020

Jacobio initiates first-in-human study of JAB-8263 in advanced solid tumors

Dec. 9, 2020

Nuvation conducts phase I/II study of NUV-422 in recurrent or refractory high-grade gliomas

Dec. 9, 2020

New vulnerability in "KL" KRAS subtype

Dec. 7, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 16, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...